These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 12745860)

  • 1. Use of intravenous abciximab as adjunctive therapy for carotid angioplasty and stent placement.
    Arab D; Yahia AM; Qureshi AI
    Int J Cardiovasc Intervent; 2003; 5(2):61-6. PubMed ID: 12745860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abciximab as an adjunct to high-risk carotid or vertebrobasilar angioplasty: preliminary experience.
    Qureshi AI; Suri MF; Khan J; Fessler RD; Guterman LR; Hopkins LN
    Neurosurgery; 2000 Jun; 46(6):1316-24; discussion 1324-5. PubMed ID: 10834637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized trial comparing phosphorylcholine-coated stenting with balloon angioplasty as well as abciximab with placebo for restenosis reduction in small coronary arteries.
    Hausleiter J; Kastrati A; Mehilli J; Schühlen H; Pache J; Dotzer F; Glatthor C; Siebert S; Dirschinger J; Schömig A;
    J Intern Med; 2004 Nov; 256(5):388-97. PubMed ID: 15485474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of intracoronary vs. intravenous administration of abciximab in coronary stenting.
    Kakkar AK; Moustapha A; Hanley HG; Weiss M; Caldito G; Misra P; Reddy PC; Tandon N
    Catheter Cardiovasc Interv; 2004 Jan; 61(1):31-4. PubMed ID: 14696156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double vessel occlusions after balloon angioplasty treated by stenting and subsequently by abciximab infusion.
    Bertrand OF; Meerkin D; de Guise P; Crépeau J; Bourassa MG
    Can J Cardiol; 2000 Jan; 16(1):83-5. PubMed ID: 10653937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does abciximab provide long-term benefit for patients with acute myocardial infarction treated with stents?
    Neumann FJ
    Nat Clin Pract Cardiovasc Med; 2006 Apr; 3(4):190-1. PubMed ID: 16568126
    [No Abstract]   [Full Text] [Related]  

  • 7. A randomized study comparing same-day home discharge and abciximab bolus only to overnight hospitalization and abciximab bolus and infusion after transradial coronary stent implantation.
    Bertrand OF; De Larochellière R; Rodés-Cabau J; Proulx G; Gleeton O; Nguyen CM; Déry JP; Barbeau G; Noël B; Larose E; Poirier P; Roy L;
    Circulation; 2006 Dec; 114(24):2636-43. PubMed ID: 17145988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long term efficacy of abciximab bolus-only compared to abciximab bolus and infusion after transradial coronary stenting.
    Bagur R; Bertrand OF; Rodés-Cabau J; Larose E; Rinfret S; Nguyen CM; Noel B; Larochellière RD; Poirier P; Costerousse O; Roy L
    Catheter Cardiovasc Interv; 2009 Dec; 74(7):1010-6. PubMed ID: 19753635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abciximab in carotid stenting for postsurgical carotid restenosis: intermediate results.
    Schneiderman J; Morag B; Gerniak A; Rimon U; Varon D; Seligsohn U; Shotan A; Adar R
    J Endovasc Ther; 2000 Aug; 7(4):263-72. PubMed ID: 10958289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical efficacy and safety of intracoronary vs. intravenous abciximab administration in STEMI patients undergoing primary percutaneous coronary intervention: a meta-analysis of randomized trials.
    Navarese EP; Kozinski M; Obonska K; Margheri M; Gurbel PA; Kubica J; De Luca G
    Platelets; 2012; 23(4):274-81. PubMed ID: 21988317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complementary clinical benefits of coronary-artery stenting and blockade of platelet glycoprotein IIb/IIIa receptors. Evaluation of Platelet IIb/IIIa Inhibition in Stenting Investigators.
    Lincoff AM; Califf RM; Moliterno DJ; Ellis SG; Ducas J; Kramer JH; Kleiman NS; Cohen EA; Booth JE; Sapp SK; Cabot CF; Topol EJ
    N Engl J Med; 1999 Jul; 341(5):319-27. PubMed ID: 10423466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracoronary compared to intravenous abciximab in patients with ST segment elevation myocardial infarction treated with primary percutaneous coronary intervention reduces mortality, target vessel revascularization and reinfarction after 1 year.
    Iversen AZ; Galatius S; Abildgaard U; Galloe A; Hansen PR; Pedersen S; Engstroem T; Jensen JS
    Cardiology; 2011; 120(1):43-9. PubMed ID: 22122887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The economics of adjunctive therapies in coronary angioplasty: drugs, devices, or both?
    Oh PI; Cohen EA; Mittmann N; Seung SJ
    Can J Clin Pharmacol; 2004; 11(2):e202-11. PubMed ID: 15520474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized comparison between tirofiban and abciximab to promote complete ST-resolution in primary angioplasty: results of the facilitated angioplasty with tirofiban or abciximab (FATA) in ST-elevation myocardial infarction trial.
    Marzocchi A; Manari A; Piovaccari G; Marrozzini C; Marra S; Magnavacchi P; Sangiorgio P; Marinucci L; Taglieri N; Gordini G; Binetti N; Guiducci V; Franco N; Reggiani ML; Saia F;
    Eur Heart J; 2008 Dec; 29(24):2972-80. PubMed ID: 18940887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronary artery stenting in MI and Abciximab: a necessary combination?
    Block PC
    Cathet Cardiovasc Diagn; 1997 Oct; 42(2):180. PubMed ID: 9377647
    [No Abstract]   [Full Text] [Related]  

  • 16. Embolic protection and platelet inhibition during renal artery stenting.
    Cooper CJ; Haller ST; Colyer W; Steffes M; Burket MW; Thomas WJ; Safian R; Reddy B; Brewster P; Ankenbrandt MA; Virmani R; Dippel E; Rocha-Singh K; Murphy TP; Kennedy DJ; Shapiro JI; D'Agostino RD; Pencina MJ; Khuder S
    Circulation; 2008 May; 117(21):2752-60. PubMed ID: 18490527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One year outcomes with abciximab vs. placebo during percutaneous coronary intervention after pre-treatment with clopidogrel.
    Schömig A; Schmitt C; Dibra A; Mehilli J; Volmer C; Schühlen H; Dirschinger J; Dotzer F; ten Berg JM; Neumann FJ; Berger PB; Kastrati A;
    Eur Heart J; 2005 Jul; 26(14):1379-84. PubMed ID: 15734767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-analysis of prospective randomized controlled trials comparing intracoronary versus intravenous abciximab in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Shimada YJ; Nakra NC; Fox JT; Kanei Y
    Am J Cardiol; 2012 Mar; 109(5):624-8. PubMed ID: 22152971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronary stenting and abciximab in primary angioplasty for ST-segment-elevation myocardial infarction.
    De Luca G; Suryapranata H; Grimaldi R; Chiariello M
    QJM; 2005 Sep; 98(9):633-41. PubMed ID: 16040669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abciximab: a review and update for clinicians.
    Mazzaferri EL; Young JJ
    Expert Rev Cardiovasc Ther; 2008 Jun; 6(5):609-18. PubMed ID: 18510478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.